Magnetic resonance imaging texture analysis to differentiate ameloblastoma from odontogenic keratocyst

Sci Rep. 2022 Nov 21;12(1):20047. doi: 10.1038/s41598-022-20802-7.

Abstract

The differentiation between ameloblastoma (AB) and odontogenic keratocyst (OKC) is essential for the formulation of the surgical plan, especially considering the biological behavior of these two pathological entities. Therefore, developing means to increase the accuracy of the diagnostic process is extremely important for a safe treatment. The aim of this study was to use magnetic resonance imaging (MRI) based on texture analysis (TA) as an aid in differentiating AB from OKC. This study comprised 18 patients; eight patients with AB and ten with OKC. All diagnoses were determined through incisional biopsy and later through histological examination of the surgical specimen. MRI was performed using a 3 T scanner with a neurovascular coil according to a specific protocol. All images were exported to segmentation software in which the volume of interest (VOI) was determined by a radiologist, who was blind to the histopathological results. Next, the textural parameters were computed by using the MATLAB software. Spearman's correlation coefficient was used to assess the correlation between texture parameters and the selected variables. Differences in TA parameters were compared between AB and OKC by using the Mann-Whitney test. Mann-Whitney test showed a statistically significant difference between AB and OKC for the parameters entropy (P = 0.033) and sum average (P = 0.033). MRI texture analysis has the potential to discriminate between AB and OKC as a noninvasive method. MRI texture analysis can be an additional tool to differentiate ameloblastoma from odontogenic keratocyst.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ameloblastoma* / diagnostic imaging
  • Ameloblastoma* / pathology
  • Humans
  • Magnetic Resonance Imaging
  • Odontogenic Cysts* / diagnostic imaging
  • Odontogenic Cysts* / pathology
  • Odontogenic Tumors*